Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Primary cutaneous anaplastic large cell lymphoma (C-ALCL) is a rare T-cell non-Hodgkin lymphoma that affects the skin and generally shows no extracutaneous involvement at presentation. It belongs to the spectrum of primary cutaneous CD30+ lymphoproliferative disorders along with lymphomatoid papulosis with which it shares overlapping clinical and histopathologic features.
Biomarker and diagnostic research for primary cutaneous anaplastic large cell lymphoma has been reported in the published literature.
Estimated prevalence: Unknown (Unknown prevalence).
2 clinical trials registered, 1 recruiting. Interventions under study include other interventions. Pipeline includes 1 NA. Research is primarily sponsored by academic and government institutions.
56 publications have been identified in PubMed for primary cutaneous anaplastic large cell lymphoma. Research spans Case Report / Case Series (46%), Review / Meta-Analysis (23%), and Other (11%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 26 |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 9:40 PM UTC
Program availability and eligibility requirements are set by each foundation. Contact them directly to learn more about your options.
Claim this page and your organization will be listed here for patients and families to find.
European rare disease database
Genetic and Rare Diseases Info Center
Research summaries | 13 | 23% |
Other research | 6 | 11% |
Disease patterns and progression | 4 | 7% |
Testing and diagnosis research | 3 | 5% |
Laboratory research | 2 | 4% |
Clinical study results | 1 | 2% |
New treatment approaches | 1 | 2% |
Tran GH (2026). [PMID: 41105046](https://pubmed.ncbi.nlm.nih.gov/41105046/). *Am J Dermatopathol*. [Case Report / Case Series]
Weiner D (2026). [PMID: 41387293](https://pubmed.ncbi.nlm.nih.gov/41387293/). *J Cutan Pathol*. [Review / Meta-Analysis]
Weisson J (2026). [PMID: 41839012](https://pubmed.ncbi.nlm.nih.gov/41839012/). *Cutis*. [Other]
Scotti B (2026). [PMID: 42200868](https://pubmed.ncbi.nlm.nih.gov/42200868/). *Reports (MDPI)*. [Case Report / Case Series]
Daniels P (2026). [PMID: 41909238](https://pubmed.ncbi.nlm.nih.gov/41909238/). *JAAD Case Rep*. [Case Report / Case Series]
Lopez-Gastelum JE (2026). [PMID: 41691664](https://pubmed.ncbi.nlm.nih.gov/41691664/). *Curr Med Imaging*. [Case Report / Case Series]
Bowers JT (2026). [PMID: 42192920](https://pubmed.ncbi.nlm.nih.gov/42192920/). *Cancers (Basel)*. [Review / Meta-Analysis]
Rajguru J (2026). [PMID: 42099190](https://pubmed.ncbi.nlm.nih.gov/42099190/). *Arch Craniofac Surg*. [Case Report / Case Series]
Kotake K (2026). [PMID: 41506792](https://pubmed.ncbi.nlm.nih.gov/41506792/). *J Cutan Pathol*. [Case Report / Case Series]
Christensen H (2026). [PMID: 42256373](https://pubmed.ncbi.nlm.nih.gov/42256373/). *JAAD Case Rep*. [Case Report / Case Series]
AI-curated news mentioning primary cutaneous anaplastic large cell lymphoma
Updated Jul 21, 2026
A 20-year study on primary cutaneous γδ T-cell lymphoma reveals significant clinical heterogeneity, providing insights into patient management and treatment strategies. This research underscores the complexity of this rare lymphoma subtype.
A recent study published in PubMed examines six cases of primary cutaneous follicular helper T-cell lymphoma, contributing valuable insights into its clinicopathological characteristics. This research enhances understanding of this rare lymphoma subtype.